Feb. 16, 2022 — This week’s news that a third person has been “cured” of HIV through a unique transplant of stem cells has given hope for a larger-scale way to beat back the HIV epidemic that has plagued the world for decades. But while this case is certainly cause for celebration, experts involved in … Read more
Michael Chancley, communications director, PrEP4All, and PrEP user. AIDSVu.org: “Local Data: Louisiana.” CDC.gov: “HIV and Women: HIV Diagnoses,” “HIV Surveillance Data Tables. Table 3a,” “PrEP Effectiveness,” FDA.gov: “FDA Approves First Injectable Treatment for HIV Pre-Exposure Prophylaxis,” Dec. 20, 2021, “FDA approves second drug to prevention HIV infection as part of ongoing efforts to end the … Read more
YouTube: “President Biden Delivers Remarks on World AIDS Day,” The White House. HIV.gov: “National HIV/AIDS Strategy for the United States 2022-2025,” “What Is Ending the HIV Epidemic in the United States?” Gregorio Millett, vice president, American Foundation for AIDS Research. amfAR: “Ending the HIV Epidemic Database.” The Lancet, Public Health: “Homelessness, unstable housing, and risk … Read more
News release, HIV.gov. Harold Phillips, director, White House Office of National AIDS Policy. Daniel Royles, PhD, assistant professor of history, Florida International University; author of To Make the Wounded Whole: The African American Struggle against HIV/AIDS. CDC: “Morbidity and Mortality Weekly Report, June 4, 2021,” “Basic Statistics,” “HIV and African American People,” “HIV and Gay … Read more
In August, when Assistant Secretary for Health Rachel Levine swore in eight new members to the President’s Advisory Council on HIV/AIDS (PACHA), the U.S.’s most influential policy sounding board of people living with HIV, their clinicians, drug makers, and public health leaders, she was presiding over the largest group of HIV advisers since former President … Read more
Sept. 2, 2021 — Over the past decade, advances in HIV treatment have yielded new drug combinations, once-daily dosing, and, most recently, the introduction of long-acting injectables for pre- and post-exposure prevention and treatment. But why has it been so difficult to make an HIV vaccine? “The difficulties of vaccine candidates that have … Read more